Aclarubicin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Aclarubicin
Aclarubicin.svg
Systematic (IUPAC) name
(1S,2S,4R)-Methyl 4-(((2S,5R,6R)-4-(dimethylamino)-5-(((1S,3R,4S)-3-hydroxy-5-methyl-4-(((2S,6R)-6-methyl-5-oxotetrahydro-2H-pyran-2-yl)oxy)cyclohexyl)oxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
Clinical data
AHFS/Drugs.com International Drug Names
Legal status
  • Prescription only
Routes IV
Identifiers
CAS number 57576-44-0 N
ATC code L01DB04
PubChem CID 42474
ChemSpider 1931 YesY
UNII 74KXF8I502 YesY
KEGG D02756 YesY
ChEBI CHEBI:74619 N
ChEMBL CHEMBL1697719 N
Chemical data
Formula C42H53NO15 
Mol. mass 811.86 g/mol
 N (what is this?)  (verify)

Aclarubicin (INN) or aclacinomycin A[1] is an anthracycline drug[2] that is used in the treatment of cancer. Soil bacteria Streptomyces galilaeus can produce aclarubicin.

References[edit]